Going back to class I: MHC and immunotherapies for childhood cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Going back to class I: MHC and immunotherapies for childhood cancer

Published:2014-12-18 Issue:4 Volume:62 Page:571-576
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Haworth Kellie B.¹,Leddon Jennifer L.²³⁴,Chen Chun‐Yu²,Horwitz Edwin M.¹²,Mackall Crystal L.⁵,Cripe Timothy P.¹²

Affiliation:

1. Division of Hematology/Oncology/Blood and Marrow TransplantNationwide Children's HospitalColumbusOhio

2. Center for Childhood Cancer and Blood DiseasesNationwide Children's HospitalColumbusOhio

3. Medical Scientist Training ProgramUniversity of CincinnatiCincinnatiOhio

4. Immunobiology Graduate Training ProgramUniversity of CincinnatiCincinnatiOhio

5. Pediatric Oncology BranchCenter for Cancer ResearchNational Cancer Institute, NIHBethesdaMaryland

Funder

Research Institute at Nationwide Children's Hospital

NIH

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.25359

Reference43 articles.

1. Childhood and adolescent cancer statistics, 2014

2. Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century

3. Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium. Nature 1999:401:921–923.

4. MHC class I antigens, immune surveillance, and tumor immune escape

5. Regulation of Immune Responses by Histone Deacetylase Inhibitors

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Divergent HLA variations and heterogeneous expression but recurrent HLA loss-of- heterozygosity and common HLA-B and TAP transcriptional silencing across advanced pediatric solid cancers;Frontiers in Immunology;2024-01-22

2. What role does GPR65 play in the progression of osteosarcoma? Its mechanism and clinical significance;Cancer Cell International;2024-01-13

3. Med23 deficiency reprograms the tumor microenvironment to promote lung tumorigenesis;British Journal of Cancer;2024-01-09

4. Balanced Epigenetic Regulation of MHC Class I Expression in Tumor Cells by the Histone Ubiquitin Modifiers BAP1 and PCGF1;The Journal of Immunology;2023-12-13

5. Adoptive cell therapy in paediatric extracranial solid tumours: current approaches and future challenges;European Journal of Cancer;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3